Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway

被引:37
作者
Anazawa, Y [1 ]
Arakawa, H [1 ]
Nakagawa, H [1 ]
Nakamura, Y [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan
基金
日本学术振兴会;
关键词
p53; p53-121F; p53 target gene; apoptosis; cDNA microarray; gene therapy;
D O I
10.1038/sj.onc.1207270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A mutant version of p53 (p53-121F), in which phenylalanine replaces the 121st serine residue, can induce apoptosis more effectively than wild-type p53 (wt-p53). In view of this observation, we considered that one or more apoptosis-related p53-target genes might be preferentially induced by p53-121F. We carried out cDNA microarray analysis to identify such genes, using mRNAs isolated from LS174T colon-cancer cells infected by adenovirus vectors containing either p53-121F(Ad-p53-121F) or wt-p53 (Ad-p53). The STAG1 gene was one of the transcripts showing higher expression levels in cells infected with Ad-p53-121F as opposed to Ad-wtp53. The encoded product appears to contain a transmembrane domain, and binding motifs for SH3 and WW. In two other cancer cell lines, the expression of STAG1 mRNA was induced in response to various genotoxic stresses in a p53-dependent manner; moreover, enforced expression of STAG1 led to apoptosis in several additional cancer cell lines. Suppression of endogenous STAG1 using the RNA-interference method reduced the apoptotic response, whether induced by Ad-p53-121F or Ad- p53. These results suggest that STAG1, a novel transcriptional target for p53, mediates p53-dependent apoptosis, and might be a good candidate for next-generation gene therapy.
引用
收藏
页码:7621 / 7627
页数:7
相关论文
共 30 条
[1]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[2]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[3]   MUTATION OF CONSERVED DOMAIN-II ALTERS THE SEQUENCE SPECIFICITY OF DNA-BINDING BY THE P53 PROTEIN [J].
FREEMAN, J ;
SCHMIDT, S ;
SCHARER, E ;
IGGO, R .
EMBO JOURNAL, 1994, 13 (22) :5393-5400
[4]  
Furuhata T, 1996, ONCOGENE, V13, P1965
[5]   A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours [J].
Habib, NA ;
Hodgson, HJF ;
Lemoine, N ;
Pignatelli, M .
HUMAN GENE THERAPY, 1999, 10 (12) :2019-2034
[6]   CSR, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress [J].
Han, HJ ;
Tokino, T ;
Nakamura, Y .
HUMAN MOLECULAR GENETICS, 1998, 7 (06) :1039-1046
[7]  
HARPER JW, 1993, CELL, V75, P805
[8]   Caspase-mediated cleavage of the ubiquitin-protein ligase Nedd4 during apoptosis [J].
Harvey, KF ;
Harvey, NL ;
Michael, JM ;
Parasivam, G ;
Waterhouse, N ;
Alnemri, ES ;
Watters, D ;
Kumar, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13524-13530
[9]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[10]  
Iiizumi M, 2002, CANCER RES, V62, P1246